Psychosomatic Health Status of Pharmacy Staff During the COVID-19 Pandemic

Qingfei Liu, Yue Sun, Yucheng Yuan, Zhen Wu, Wenhao Jiang, Yonggui YuanResearch 2021 · DOI

Introduction

During the peak of the COVID-19 pandemic, healthcare research predominantly focused on the mental health of doctors and nurses. However, pharmacy staff served as a critical yet understudied frontline group, facing high infection risks and intense psychological pressure from anxious patients. This study investigates the incidence and risk factors of psychosomatic syndrome—physical symptoms caused or aggravated by mental stress—among pharmacy workers in China.

Methods

A large-scale cross-sectional online survey was conducted via WeChat over 22 days during the initial outbreak. The study utilized the Psychosomatic Symptoms Scale (PSSS), a 26-item instrument measuring psychological factors (e.g., irritability) and somatic factors (e.g., sleep issues). Data from 9,118 valid participants across 31 provinces were analyzed using ANOVA to identify subgroup differences and multiple stepwise linear regression to determine primary risk factors.

Demographic Vulnerabilities

The study revealed an overall psychosomatic syndrome incidence rate of 21.7%. Analysis of demographic subgroups showed significant variations, particularly concerning age and marital status.

Incidence and PSSS scores across demographic groups

Notably, older staff (≥51 years) exhibited the highest incidence rate at 61.06%, suggesting that a weakening of social supports and the physical toll of aging may exacerbate pandemic-related stress. Gender also played a role, with females reporting significantly higher psychological distress scores (4.64) compared to males (4.24).

Key Risk Factors

Regression analysis identified age and education as the most critical predictors of psychosomatic health.

Multiple linear regression analysis of PSSS total scores

While age was the strongest predictor for total PSSS scores and somatic symptoms, education level emerged as a primary factor for psychological symptoms. Higher education levels, particularly at the postgraduate level, correlated with lower incidence rates, potentially due to more effective coping mechanisms or better access to health information.

Conclusion

The findings highlight that over one-fifth of pharmacy staff experienced significant psychosomatic distress, primarily manifesting as sleep disturbances (32.47%) and irritability (31.40%). These results underscore the need for targeted mental health interventions for pharmacy professionals, focusing on sleep quality and mood regulation, with special attention paid to older staff members.

Summary updated

Abstract

Abstract Background: Few studies have been conducted on psychosomatic health status of pharmacy staff during the COVID-19 pandemic. This study aims to investigate the incidence and influence factors of psychosomatic syndrome of pharmacy staff during the COVID-19 pandemic. Methods: A total of 10721 pharmacy staff received online investigation through a period of 22 days from February 24 th to March 16 th 2019. The investigation included the self-designed general situation questionnaire and Psychosomatic Symptoms Scale (PSSS), and 9118 participants provided valid questionnaire feedback. ANOVA was used to evaluate significant differences of psychosomatic syndromes in different subgroups. Multiple stepwise linear regression analysis was used to determine the main risk factors of psychosomatic syndrome. Results: During the outbreak of COVID-19, the total incidence of psychosomatic syndrome was 21.7% in the pharmacy staff. The most common psychosomatic symptoms were sleep problems (dyscoimesis) and mood problems (irritability). Age was the most important risk factor of the observed psychosomatic syndromes and somatic symptoms, and education was identified affecting mostly psychological symptoms. Conclusion: During the period of COVID-19, the psychosomatic problems of pharmacy staff were prominent. Age and educational background should be taken into account of potential intervention strategy. The relief of mood and sleep will aid the treatment effort.
BibTeX
@inproceedings{liu2021psychosomatic,
  author = {Qingfei Liu and Yue Sun and Yucheng Yuan and Zhen Wu and Wenhao Jiang and Yonggui Yuan},
  title = {{Psychosomatic Health Status of Pharmacy Staff During the COVID-19 Pandemic}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-263883/v1},
}
Figure